The global fertility supplements market size is calculated at USD 2.42 billion in 2025 and is forecasted to reach around USD 4.85 billion by 2034, accelerating at a CAGR of 8.04% from 2025 to 2034. The North America market size surpassed USD 810 million in 2024 and is expanding at a CAGR of 8.13% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Fertility Supplements Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Fertility Supplements Market Revenue and Volume Forecast, by Ingredient Type
8.1.1. Natural
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Synthetic/ Blend of Natural and Synthetic
8.1.2.1. Market Revenue and Volume Forecast
9.1. Fertility Supplements Market Revenue and Volume Forecast, by Product
9.1.1. Capsules
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Tablets
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Soft Gels
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Powders
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Liquids
9.1.5.1. Market Revenue and Volume Forecast
10.1. Fertility Supplements Market Revenue and Volume Forecast, by End-User
10.1.1. Men
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Women
10.1.2.1. Market Revenue and Volume Forecast
11.1. Fertility Supplements Market Revenue and Volume Forecast, by Distribution Channel
11.1.1. OTC
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Prescribed
11.1.2.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Ingredient Type
12.1.2. Market Revenue and Volume Forecast, by Product
12.1.3. Market Revenue and Volume Forecast, by End-User
12.1.4. Market Revenue and Volume Forecast, by Distribution Channel
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Ingredient Type
12.1.5.2. Market Revenue and Volume Forecast, by Product
12.1.5.3. Market Revenue and Volume Forecast, by End-User
12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Ingredient Type
12.1.6.2. Market Revenue and Volume Forecast, by Product
12.1.6.3. Market Revenue and Volume Forecast, by End-User
12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Ingredient Type
12.2.2. Market Revenue and Volume Forecast, by Product
12.2.3. Market Revenue and Volume Forecast, by End-User
12.2.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Ingredient Type
12.2.5.2. Market Revenue and Volume Forecast, by Product
12.2.5.3. Market Revenue and Volume Forecast, by End-User
12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Ingredient Type
12.2.6.2. Market Revenue and Volume Forecast, by Product
12.2.6.3. Market Revenue and Volume Forecast, by End-User
12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Ingredient Type
12.2.7.2. Market Revenue and Volume Forecast, by Product
12.2.7.3. Market Revenue and Volume Forecast, by End-User
12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Ingredient Type
12.2.8.2. Market Revenue and Volume Forecast, by Product
12.2.8.3. Market Revenue and Volume Forecast, by End-User
12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Ingredient Type
12.3.2. Market Revenue and Volume Forecast, by Product
12.3.3. Market Revenue and Volume Forecast, by End-User
12.3.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Ingredient Type
12.3.5.2. Market Revenue and Volume Forecast, by Product
12.3.5.3. Market Revenue and Volume Forecast, by End-User
12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Ingredient Type
12.3.6.2. Market Revenue and Volume Forecast, by Product
12.3.6.3. Market Revenue and Volume Forecast, by End-User
12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Ingredient Type
12.3.7.2. Market Revenue and Volume Forecast, by Product
12.3.7.3. Market Revenue and Volume Forecast, by End-User
12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Ingredient Type
12.3.8.2. Market Revenue and Volume Forecast, by Product
12.3.8.3. Market Revenue and Volume Forecast, by End-User
12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Ingredient Type
12.4.2. Market Revenue and Volume Forecast, by Product
12.4.3. Market Revenue and Volume Forecast, by End-User
12.4.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Ingredient Type
12.4.5.2. Market Revenue and Volume Forecast, by Product
12.4.5.3. Market Revenue and Volume Forecast, by End-User
12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Ingredient Type
12.4.6.2. Market Revenue and Volume Forecast, by Product
12.4.6.3. Market Revenue and Volume Forecast, by End-User
12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Ingredient Type
12.4.7.2. Market Revenue and Volume Forecast, by Product
12.4.7.3. Market Revenue and Volume Forecast, by End-User
12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Ingredient Type
12.4.8.2. Market Revenue and Volume Forecast, by Product
12.4.8.3. Market Revenue and Volume Forecast, by End-User
12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Ingredient Type
12.5.2. Market Revenue and Volume Forecast, by Product
12.5.3. Market Revenue and Volume Forecast, by End-User
12.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Ingredient Type
12.5.5.2. Market Revenue and Volume Forecast, by Product
12.5.5.3. Market Revenue and Volume Forecast, by End-User
12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Ingredient Type
12.5.6.2. Market Revenue and Volume Forecast, by Product
12.5.6.3. Market Revenue and Volume Forecast, by End-User
12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel
13.1. Fairhaven Health
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Coast Science
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Lenus Pharma GesmbH
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Active Bio Life Science GmbH
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Orthomol
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Exeltis USA, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Bionova
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Fertility Nutraceuticals LLC
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Vitabiotics Ltd.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Extreme V, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample